Brainstorm Cell Therapeutics Files 8-K with Key Agreements
Ticker: BCLI · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1137883
| Field | Detail |
|---|---|
| Company | Brainstorm Cell Therapeutics Inc. (BCLI) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, financial-reporting
TL;DR
Brainstorm Cell Therapeutics filed an 8-K on 3/31/25 covering material agreements and equity sales.
AI Summary
On March 31, 2025, Brainstorm Cell Therapeutics Inc. filed an 8-K report detailing a material definitive agreement and unregistered sales of equity securities. The filing also included financial statements and exhibits, indicating ongoing corporate activities and financial reporting.
Why It Matters
This 8-K filing signals significant corporate actions and financial disclosures for Brainstorm Cell Therapeutics Inc., potentially impacting investors and stakeholders.
Risk Assessment
Risk Level: medium — 8-K filings can indicate significant corporate events, but the specific details of the agreements and sales are not yet fully disclosed in this summary.
Key Players & Entities
- Brainstorm Cell Therapeutics Inc. (company) — Registrant
- March 31, 2025 (date) — Date of earliest event reported
FAQ
What was the nature of the material definitive agreement filed on March 31, 2025?
The filing indicates an "Entry into a Material Definitive Agreement" but does not provide specific details of the agreement in the provided text.
What type of equity securities were sold in the unregistered sale?
The filing mentions "Unregistered Sales of Equity Securities" but does not specify the type or amount of securities sold.
What financial statements and exhibits were included in the filing?
The filing states that "Financial Statements and Exhibits" were included, but the specific content is not detailed in the provided text.
What is Brainstorm Cell Therapeutics Inc.'s SIC code?
Brainstorm Cell Therapeutics Inc.'s Standard Industrial Classification (SIC) code is 2836, for Biological Products (No Diagnostic Substances).
When was Brainstorm Cell Therapeutics Inc. incorporated?
Brainstorm Cell Therapeutics Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding BRAINSTORM CELL THERAPEUTICS INC. (BCLI).